박지수

  #장기 암생존자 관리#암 고위험군 진료

학력

연세대학교 의과대학 졸업 (2006)
연세대학교 대학원 의학과 석사 (2013)
연세대학교 대학원 의학과 박사 (2018)

경력

2007.3~2008.2 강남세브란스병원 인턴 수료
2008.3~2012.2 강남세브란스병원 내과 레지던트 수료
2012.3~2013.2 세브란스병원 암센터 종양내과 강사
2013.3~2014.3 세브란스병원 암센터 종양내과 임상연구조교수
2014.4~2015.3 연세의료원 연세암병원 암예방센터 계약의사
2015.4~ 현재 연세의료원 연세암병원 암예방센터 임상조교수

논문

A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs.
LUNG CANCER 134/ :46-51,2019

Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
Journal of Cancer Prevention 24/1 :48-53,2019

Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5’ and 3’ Exons
ANTICANCER RESEARCH 38/12 :6,947-6,953,2018

Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers.
CLINICAL BREAST CANCER 18/5 :362-373,2018

The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status
GASTRIC CANCER 21/2 :213-224,2018

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2.
CANCER RESEARCH AND TREATMENT 50/3 :917-925,2018

Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence
PLOS ONE 13/3 :e0193753-1-e0193753-13,2018

Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer
BMC CANCER 18/1 :83-90,2018

Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
CANCER RESEARCH AND TREATMENT 49/4 :1,012-1,021,2017

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
ONCOTARGET 8/37 :61,837-61,845,2017

The effects of physical activity and body fat mass on colorectal polyp recurrence in patients with previous colorectal cancer
CANCER PREVENTION RESEARCH 10/8 :478-484,2017

Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
CANCER RESEARCH AND TREATMENT 49/2 :408-415,2017

BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients
GYNECOLOGIC ONCOLOGY 145/1 :137-141,2017

Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm
ONCOTARGET 7/44 :72,099-72,112,2016

Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.
CANCER RESEARCH AND TREATMENT 48/4 :1253-1263,2016

Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 46/6 :507-516,2016

High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 142/9 :2051-2059,2016

유전체 의학 시대를 맞이한 유전성 유방암-난소암 증후군 유전 검사의 임상적 함의: 임상의사가 바라본 전망
Journal of Breast Disease 4/1 :1-9,2016

Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
ONCOLOGY 88/3 :147-156,2015

The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer
LUNG CANCER 88/3 :325-331,2015

PTEN Deficiency as a Predictive Biomarker of Resistance to HER2-Targeted Therapy in Advanced Gastric Cancer
ONCOLOGY 88/2 :76-85,2015

Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma
JOURNAL OF NEURO-ONCOLOGY 120/1 :199-207,2014

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
CANCER CHEMOTHERAPY AND PHARMACOLOGY 74/4 :799-808,2014

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
LUNG CANCER 83/3 :389-395,2014

Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 43/10 :996-1003,2013

Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer
LUNG CANCER 80/3 :313-318,2013

복강 내에서 발견된 기관지원성낭종 내의 선암 1예
대한내과학회지 82/3 :374-377,2012

Spontaneous Sinus Conversion of Permanent Atrial Fibrillation During Treatment of Hyperkalemia
Korean Circulation Journal(순환기) 42/1 :65-68,2012

Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Cancer Research and Treatment 43/4 :236-243,2011

저서

저서 내용이 없습니다.

보도자료

[서울경제] [건강 팁] 가족성·유전성 암 예방 - 연세암병원 암예방센터 ...
http://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=103&oid=011&aid=0003636734

[헤럴드경제] 암 수술 후 채식 ‘올인’…단백질 부족 땐 ‘헛일’ - 연세...
http://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=103&oid=016&aid=0001545056

[헤럴드경제] 금연?금주만 잘해도…암, 절반이상 예방 - 연세암...
http://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=016&aid=0001513126

포스팅

포스팅 내용이 없습니다.

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.